Mynd Life SciencesJun 15, 2021MYND Life Sciences to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual ConfeVANCOUVER, BC, June 15, 2021 /PRNewswire/ – MYND Life Sciences Inc. (CSE: MYND) (“MYND“) a drug research and development company focused...
Mynd Life SciencesJun 10, 2021MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder DrugsVANCOUVER, BC, June 10, 2021 /CNW/ – MYND Life Sciences Inc. (CSE: MYND) (“MYND“) a drug research and development company focused on...
Mynd Life SciencesJun 1, 2021MYND Life Sciences announces Depression Biomarker Diagnostic ProgramVANCOUVER, BC, June 1, 2021 /CNW/ – MYND Life Sciences Inc. (CSE: MYND) (“MYND“) a drug research and development company focused on novel...